Search | Page 2 | ASTRO

ASTRO/JASTRO Joint Session: Advances in Liver Cancer Radiation Therapy
Advances in Breast Cancer Management: Early-Stage Disease, Post-Neoadjuvant Radiation Therapy and IMRT for Breast Cancer Treatment in a Community Setting
Management of Unfavorable Intermediate-Risk Prostate Cancer: Role of SBRT, Brachytherapy and Androgen Deprivation
Management of Small Cell Neuroendocrine Tumors of the Genitourinary Tract
Implementation of a Prostate SBRT Program in the Community Setting
Fine ART: Ever Evolving Online Adaptive Radiotherapy Technologies and Clinical Innovations
Prevention and Management of Toxicity in Organs at Risk (OAR) in a Community Setting
Integration of HPV ctDNA Testing into Clinical Practice for HPV+ OPSCC – Ready for Prime Time?
A Case-Based Interactive Discussion of the ASTRO Clinical Practice Guideline for HPV-Positive Oropharyngeal Squamous Cell Carcinoma
Multimodality Treatment De-Intensification in Low-Risk Breast Cancer: What Are the Limits?
How to Optimally Deliver Vaginal Cuff Brachytherapy for Endometrial Cancer in Your Practice: Tips and Tricks From the Experts
The Evolution of Cancer Within a Patient: Tumor Phylogenetics and Implications for Local Therapy
Brain Metastases Radiotherapy While Mitigating Radionecrosis and Neurotoxicity in a Community Setting
Gynecologic Tumor Board–Case-Based Discussion of the Molecular & Treatment Approach Updates for the Management of Endometrial, Vulvar & Cervical Cancers
Salvage Therapy for Local-Regional Breast Cancer Recurrence: What, When, and How Much?
The Hidden Risks of Artificial Intelligence (AI): Biases and Disparities in the Global Development and Deployment of AI for Cancer Care
“Let’s Talk About It!” - Biology and Management of Sexual Toxicity Resulting from Prostate Cancer Radiotherapy
Simplifying Bone Mets
Best Practices in the Multidisciplinary Management of Borderline Resectable and Unresectable Pancreatic Cancer as well as Extrahepatic/Perihilar Cholangiocarcinoma
Contemporary FLASH-RT to Its Clinical Translation
How High Can We Go - How Low Should We Aim? Normal Tissue Dose/Volume Constraints in Lymphoma Radiation Therapy Planning
Intersection of Immuno-Molecular-Genetic Profiling and Implications for Immunotherapy (IT) and Immunotherapy-Radiotherapy (IT-RT) Combinations
Treatment De-Escalation Strategies for Locally Advanced Rectal Cancer
Relevant or Relegated? Radiotherapy for Stage III NSCLC in the Neoadjuvant Era
Integrating Focal Therapies and Radiation for Enhanced Systemic Immune Modulation

Pages